Skip to main content
This website uses cookies. By continuing to use this website you are agreeing to our use of cookies as described in our privacy policy.
Client Work

GenoLogics Life Sciences Software closes Series B financing for US$5.5 million

Fasken
Reading Time 1 minute read Subscribe
Client

GenoLogics Life Science Software Inc.

On October 31, 2006, GenoLogics Life Sciences Software Inc., a leading developer of lab and scientific data management solutions, announced that it had completed a $5.5 million Series B round of financing led by OVP Venture Partners in Seattle, along with Growth Works and Yaletown Venture Partners. Proceeds of the financing will go toward GenoLogics' sales and marketing efforts for the January 2007 launch of its second product. Based in Victoria, British Columbia, GenoLogics serves about 30 pharmaceutical companies and academic institutions with its first product focused on the proteomics market. Fasken Martineau advised GenoLogics in this financing with a team comprised of Keith Spencer, Karima Penman and Frank Schober.

    Subscribe

    Receive email updates from our team

    Subscribe